for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

OTSUKA CORPORATION

4768.T

Latest Trade

4,635.00JPY

Change

85.00(+1.87%)

Volume

533,800

Today's Range

4,600.00

 - 

4,670.00

52 Week Range

3,290.00

 - 

4,820.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Verily Forms Strategic Alliances With Novartis, Otsuka, Pfizer And Sanofi To Transform Clinical Research

May 21 (Reuters) - Verily, Novartis, Otsuka, Pfizer And Sanofi::VERILY FORMS STRATEGIC ALLIANCES WITH NOVARTIS, OTSUKA, PFIZER AND SANOFI TO TRANSFORM CLINICAL RESEARCH.VERILY FORMS STRATEGIC ALLIANCES WITH NOVARTIS, OTSUKA, PFIZER AND SANOFI TO TRANSFORM CLINICAL RESEARCH.VERILY - BIOPHARMACEUTICAL ORGANIZATIONS JOIN PROJECT BASELINE INITIATIVE TO ENGAGE MORE PATIENTS AND CLINICIANS IN RESEARCH.

Otsuka announces results of phase 3 data on tolvaptan

May 22 (Reuters) - Otsuka Holdings Co Ltd <4578.T>:Otsuka announces results of phase 3 data on tolvaptan.Says primary and key secondary endpoints were positive for tolvaptan versus placebo in an additional phase 3 clinical trial.Data are intended to address complete response letter issued by FDA for a new drug application for tolvaptan in ADPKD in 2013.Says there were no new safety issues identified for tolvaptan during trial.

Otsuka's 9-month group operating profit seen at about 28 bln yen - Nikkei

Nikkei: Otsuka Corp is expected to report group operating profit for the period through Sept. 30 is seen at around 28 billion yen - Nikkei . Sales for Otsuka are likely to grow 4% to around 470 billion yen for the 9 month period through Sept. 30 - Nikkei .Otsuka is expected to keep FY earnings guidance unchanged when it reports 9 month results, with operating profit forecast to rise 7% to 40 bln yen - Nikkei.

Alkermes says U.S. District Court issued unambiguous opinion in favor of co, U.S. FDA - SEC filing

Alkermes Plc: On July 28 U.S. District Court for District of Columbia issued unambiguous opinion in favor of co and U.S. FDA - SEC filing . U.S. District Court unambiguous opinion affirming in all respects FDA's decision to approve Aristada for treatment of schizophrenia .U.S. District Court unambiguous opinion also "denying action filed by Otsuka for declaratory and injunctive relief".

Otsuka Corp's group net profit apparently grew 9% for the January-June half of 2016 - Nikkei

: Otsuka Corp likely earned 16 billion yen ($155 million) or so for the January-June half of 2016 - Nikkei . Otsuka Corp likely earned 16 billion yen ($155 million) or so for the January-June half of 2016 - Nikkei . Otsuka Corp likely earned 16 billion yen ($155 million) or so for the January-June half of 2016 - Nikkei Source - http://s.nikkei.com/29eF6He (Bengaluru Newsroom; +1 646 223 8780).

OTSUKA to issue year-end dividend for FY 2015

OTSUKA CORP:To issue a year-end dividend of 100 yen per share to all the shareholders for the fiscal year ended Dec. 31, 2015.Payment date March 30, 2016.Says the dividend amount is above the latest forecast disclosed on Feb. 2.

OTSUKA to issue year-end dividend for FY 2014

OTSUKA CORP:To issue a year-end dividend of 90 yen per share to all the shareholders of record as of Dec. 31, for FY ended Dec. 2014.Payment date March 30.Says latest dividend forecast was 80 yen per share.

OTSUKA revises year-end dividend forecast for FY 2014

OTSUKA CORP:Sees year-end dividend of 80 yen per share revised from 240 yen per share for fiscal year ending Dec. 2014, due to stock split on July 1.

OTSUKA CORP to pay year-end dividend for FY 2013

OTSUKA CORP:Says to pay a year-end dividend of 235 yen per share (7,426 million yen in total), above the latest dividend forecast of 205 yen per share, for fiscal year ended Dec. 2013.Says record date of Dec. 31, 2013 and effective date of Mar. 28.

OTSUKA CORP Announces Subsidiary's Former Employee's Misconduct

OTSUKA CORP announced that its internal investigation committee has found that a former employee of its subsidiary made false business transaction regarding an interior work which he was in charge of.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up